Time trends of left ventricular ejection fraction and myocardial deformation indices in a cohort of women with breast cancer treated with anthracyclines, taxanes, and trastuzumab

Journal of the American Society of Echocardiography

Volumn 28, Issue 5, 2015, Pages 509-514

  Tan, Timothy C ^a   Bouras, Souhila ^a   Sawaya, Heloisa ^a   Sebag, Igal A ^c   Cohen, Victor ^d,e   Picard, Michael H ^a   Passeri, Jonathan ^a   Kuter, Irene ^b   Scherrer Crosbie, Marielle ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Breast cancer; Cardiotoxicity; Echocardiography; LVEF; Strain; Strain rate

Indexed keywords

ANTHRACYCLINE DERIVATIVE; DOXORUBICIN; EPIRUBICIN; PACLITAXEL; TAXANE DERIVATIVE; TRASTUZUMAB; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; TAXOID;

ADULT; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CARDIOTOXICITY; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; COHORT ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART SIZE; HUMAN; TIME; TIME TREND; BREAST NEOPLASMS; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECTS; ECHOGRAPHY; HEART STROKE VOLUME; HEART VENTRICLE; HEART VOLUME; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY;

ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARDIAC VOLUME; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE VOLUME; TAXOIDS; TIME FACTORS; TRASTUZUMAB; VENTRICULAR FUNCTION, LEFT;

EID: 84929504896     PISSN: 08947317     EISSN: 10976795     Source Type: Journal    
DOI: 10.1016/j.echo.2015.02.001     Document Type: Article

References (51)

1. R.L. Siegel, E.M. Ward, and A. Jemal Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008 Cancer Epidemiol Biomarkers Prev 21 2012 411 416
2. M.C. Pinder, Z. Duan, J.S. Goodwin, G.N. Hortobagyi, and S.H. Giordano Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer J Clin Oncol 25 2007 3808 3815
3. J.L. Patnaik, T. Byers, C. DiGuiseppi, D. Dabelea, and T.D. Denberg Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study Breast Cancer Res 13 2011 R64
4. P.K. Singal, and N. Iliskovic Doxorubicin-induced cardiomyopathy N Engl J Med 339 1998 900 905
5. G.M. Felker, R.E. Thompson, J.M. Hare, R.H. Hruban, D.E. Clemetson, and D.L. Howard Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy N Engl J Med 342 2000 1077 1084
6. K.F. Adams Jr., S.H. Dunlap, C.A. Sueta, S.W. Clarke, J.H. Patterson, and M.B. Blauwet Relation between gender, etiology and survival in patients with symptomatic heart failure J Am Coll Cardiol 28 1996 1781 1788
7. D.D. Von Hoff, M. Rozencweig, M. Layard, M. Slavik, and F.M. Muggia Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases Am J Med 62 1977 200 208
8. S.M. Swain, F.S. Whaley, and M.S. Ewer Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials Cancer 97 2003 2869 2879
9. B. Coiffier, E. Lepage, J. Briere, R. Herbrecht, H. Tilly, and R. Bouabdallah CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma N Engl J Med 346 2002 235 242
10. S.H. Giordano, Y.L. Lin, Y.F. Kuo, G.N. Hortobagyi, and J.S. Goodwin Decline in the use of anthracyclines for breast cancer J Clin Oncol 30 2012 2232 2239
11. J.F. Bishop, J. Dewar, G.C. Toner, J. Smith, M.H. Tattersall, and I.N. Olver Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer J Clin Oncol 17 1999 2355 2364
12. S. Chan, K. Friedrichs, D. Noel, T. Pinter, S. Van Belle, and D. Vorobiof Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer J Clin Oncol 17 1999 2341 2354
13. V. Guarneri, D.J. Lenihan, V. Valero, J.B. Durand, K. Broglio, and K.R. Hess Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the M.D. Anderson Cancer Center experience J Clin Oncol 24 2006 4107 4115
14. Y. Yarden, and M.X. Sliwkowski Untangling the ErbB signalling network Nat Rev Mol Cell Biol 2 2001 127 137
15. A. Gschwind, O.M. Fischer, and A. Ullrich The discovery of receptor tyrosine kinases: targets for cancer therapy Nat Rev Cancer 4 2004 361 370
16. D.J. Slamon, G.M. Clark, S.G. Wong, W.J. Levin, A. Ullrich, and W.L. McGuire Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 1987 177 182
17. D.J. Slamon, W. Godolphin, L.A. Jones, J.A. Holt, S.G. Wong, and D.E. Keith Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer Science 244 1989 707 712
18. M. Guglin, R. Cutro, and J.D. Mishkin Trastuzumab-induced cardiomyopathy J Card Fail 14 2008 437 444
19. D. Slamon, W. Eiermann, N. Robert, T. Pienkowski, M. Martin, and M. Press Adjuvant trastuzumab in HER2-positive breast cancer N Engl J Med 365 2011 1273 1283
20. D.L. Keefe Trastuzumab-associated cardiotoxicity Cancer 95 2002 1592 1600
21. E.A. Perez, and R. Rodeheffer Clinical cardiac tolerability of trastuzumab J Clin Oncol 22 2004 322 329
22. L. Moja, L. Tagliabue, S. Balduzzi, E. Parmelli, V. Pistotti, and V. Guarneri Trastuzumab containing regimens for early breast cancer Cochrane Database Syst Rev 4 2012 CD006243
23. M.S. Ewer, and S.M. Lippman Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity J Clin Oncol 23 2005 2900 2902
24. L. Gianni, E.H. Herman, S.E. Lipshultz, G. Minotti, N. Sarvazyan, and D.B. Sawyer Anthracycline cardiotoxicity: from bench to bedside J Clin Oncol 26 2008 3777 3784
25. T. Force, D.S. Krause, and R.A. Van Etten Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition Nat Rev Cancer 7 2007 332 344
26. M.S. Ewer, M.T. Vooletich, J.B. Durand, M.L. Woods, J.R. Davis, and V. Valero Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment J Clin Oncol 23 2005 7820 7826
27. J. Rickard, D.J. Kumbhani, B. Baranowski, D.O. Martin, W.H. Tang, and B.L. Wilkoff Usefulness of cardiac resynchronization therapy in patients with Adriamycin-induced cardiomyopathy Am J Cardiol 105 2010 522 526
28. L. Oreto, M.C. Todaro, M.M. Umland, C. Kramer, R. Qamar, and S. Carerj Use of echocardiography to evaluate the cardiac effects of therapies used in cancer treatment: what do we know? J Am Soc Echocardiogr 25 2012 1141 1152
29. D. Cardinale, A. Colombo, G. Lamantia, N. Colombo, M. Civelli, and G. De Giacomi Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy J Am Coll Cardiol 55 2010 213 220
30. C. Huang, X. Zhang, J.M. Ramil, S. Rikka, L. Kim, and Y. Lee Juvenile exposure to anthracyclines impairs cardiac progenitor cell function and vascularization resulting in greater susceptibility to stress-induced myocardial injury in adult mice Circulation 121 2010 675 683
31. S.E. Lipshultz, S.D. Colan, R.D. Gelber, A.R. Perez-Atayde, S.E. Sallan, and S.P. Sanders Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood N Engl J Med 324 1991 808 815
32. L. Steinherz, and P. Steinherz Delayed cardiac toxicity from anthracycline therapy Pediatrician 18 1991 49 52
33. K. Negishi, T. Negishi, J.L. Hare, B.A. Haluska, J.C. Plana, and T.H. Marwick Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity J Am Soc Echocardiogr 26 2013 493 498
34. H. Sawaya, I.A. Sebag, J.C. Plana, J.L. Januzzi, B. Ky, and V. Cohen Early detection and prediction of cardiotoxicity in chemotherapy-treated patients Am J Cardiol 107 2011 1375 1380
35. H. Sawaya, I.A. Sebag, J.C. Plana, J.L. Januzzi, B. Ky, and T.C. Tan Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab Circ Cardiovasc Imaging 5 2012 596 603
36. T. Yingchoncharoen, S. Agarwal, Z.B. Popovic, and T.H. Marwick Normal ranges of left ventricular strain: a meta-analysis J Am Soc Echocardiogr 26 2013 185 191
37. A. Seidman, C. Hudis, M.K. Pierri, S. Shak, V. Paton, and M. Ashby Cardiac dysfunction in the trastuzumab clinical trials experience J Clin Oncol 20 2002 1215 1221
38. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, and P.A. Pellikka Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
39. S.E. Lipshultz, T.L. Miller, R.E. Scully, S.R. Lipsitz, N. Rifai, and L.B. Silverman Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes J Clin Oncol 30 2012 1042 1049
40. M. Amigoni, C. Giannattasio, D. Fraschini, M. Galbiati, A.C. Capra, and F. Madotto Low anthracyclines doses-induced cardiotoxicity in acute lymphoblastic leukemia long-term female survivors Pediatr Blood Cancer 55 2010 1343 1347
41. D. Iarussi, M. Galderisi, G. Ratti, M.A. Tedesco, P. Indolfi, and F. Casale Left ventricular systolic and diastolic function after anthracycline chemotherapy in childhood Clin Cardiol 24 2001 663 669
42. J.C. Plana, M. Galderisi, A. Barac, M.S. Ewer, B. Ky, and M. Scherrer-Crosbie Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging J Am Soc Echocardiogr 27 2014 911 939
43. E. Tan-Chiu, G. Yothers, E. Romond, C.E. Geyer Jr., M. Ewer, and D. Keefe Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31 J Clin Oncol 23 2005 7811 7819
44. M.L. Telli, S.A. Hunt, R.W. Carlson, and A.E. Guardino Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility J Clin Oncol 25 2007 3525 3533
45. G. Milano, A. Raucci, A. Scopece, R. Daniele, U. Guerrini, and L. Sironi Doxorubicin and trastuzumab regimen induces biventricular failure in mice J Am Soc Echocardiogr 27 2014 568 579
46. P. Lancellotti, V.T. Nkomo, L.P. Badano, J. Bergler-Klein, J. Bogaert, and L. Davin Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography J Am Soc Echocardiogr 26 2013 1013 1032
47. E.H. Romond, J.H. Jeong, P. Rastogi, S.M. Swain, C.E. Geyer Jr., and M.S. Ewer Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer J Clin Oncol 30 2012 3792 3799
48. T.G. Neilan, D.S. Jassal, T.M. Perez-Sanz, M.J. Raher, A.D. Pradhan, and E.S. Buys Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury Eur Heart J 27 2006 1868 1875
49. J.T. Poterucha, S. Kutty, R.K. Lindquist, L. Li, and B.W. Eidem Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction J Am Soc Echocardiogr 25 2012 733 740
50. P.W. Stoodley, D.A. Richards, R. Hui, A. Boyd, P.R. Harnett, and S.R. Meikle Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy Eur J Echocardiogr 12 2011 945 952
51. J.E. Otterstad, G. Froeland, M. St John Sutton, and I. Holme Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function Eur Heart J 18 1997 507 513